INBRIJA Co-pay Programs and Other Financial Assistance
Commercially insured patients may be eligible to receive their first prescription of INBRIJA–up to five 30-dose cartons–free with a $0 co-pay*
Ongoing co-pay mitigation is available to commercially insured patients who receive INBRIJA for as little as $30 per month†
No-cost medication to patients who meet specific program eligibility requirements
CASH PAY PROGRAM
INBRIJA is available to eligible cash-paying patients for $195 per carton‡
*The dispensing pharmacy will submit a claim to the patient’s insurance carrier. Acorda Therapeutics, Inc. will reimburse the dispensing pharmacy in the amount of the patient’s required financial contribution as determined based on the patient’s pharmacy benefit plan.
†Please note, restrictions apply to Acorda’s co-pay assistance program, including monthly and yearly maximums. Acorda may modify these maximums or discontinue the program at any time. In this case, any change to what commercial patients are required to pay will be communicated to patients by their specialty pharmacy. The actual amount patients have to pay will vary depending upon these maximums and their insurance benefit.
‡Patients purchasing INBRIJA through the Direct Cash Purchase Program must meet eligibility criteria which Acorda Therapeutics may modify in its sole discretion at any time. Sales of INBRIJA through the program will be made directly from Acorda to the patient, although product will be dispensed by a licensed pharmacy. Patients purchasing through the program may not access insurance benefits or seek reimbursement in connection with dispenses made through the program.